Concepedia

William Canovatchel

WC

Statistics

Publications

30

Citations

5.1K

H-Index

22

Active since

1992

Affiliations

Janssen (United States)(Current)

Pennington Biomedical Research Center

St. Michael's Hospital

Janssen (Belgium)

University of Toronto

William Canovatchel is an author at Janssen (United States) specializing in medicine, diabetology, and pharmacology.

ORCID

Publications per year

1992–2020

30

Publications

30

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

William T. Cefalu, Lawrence A. Leiter, Kun‐Ho Yoon et al. · The Lancet · 2013 · 724 citations

, , +15

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Priscilla Hollander, Steven C. Elbein, Irl B. Hirsch et al. · Diabetes Care · 1998 · 657 citations

, , +17

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

Kaj Stenlöf, William T. Cefalu, Kyung‐Ah Kim et al. · Diabetes Obesity and Metabolism · 2012 · 611 citations · Full text

, , +17

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

Fernando J. Lavalle‐González, Andrzej Januszewicz, Jaime A. Davidson et al. · Diabetologia · 2013 · 497 citations · Full text

, , +17

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

Guntram Schernthaner, Jorge Luiz Gross, Julio Rosenstock et al. · Diabetes Care · 2013 · 479 citations · Full text

, , +15

1–5 of 30